Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/8292
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSrivastava, Pavan-
dc.contributor.authorVyas, Vivek K.-
dc.contributor.authorVariya, Bhavesh-
dc.contributor.authorPatel, Palak-
dc.contributor.authorQureshi, Gulamnizami-
dc.date.accessioned2019-04-03T10:42:31Z-
dc.date.available2019-04-03T10:42:31Z-
dc.date.issued2016-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/8292-
dc.descriptionBio organic Chemistry; 67 (2016): 130–138en_US
dc.description.abstractIn the present study, 7-subsituted coumarin derivatives were synthesized using various aromatic and heterocyclic amines, and evaluated in vivo for anti-inflammatory and analgesic activity, and for ulcerogenic risk. The most active compounds were evaluated in vitro for 5-lipoxygenase (5-LOX) inhibition. Docking study was performed to predict the binding affinity, and orientation at the active site of the enzyme. In vivo anti-inflammatory and analgesic activity, and in vitro 5-LOX enzyme inhibition study revealed that compound 33 and 35 are the most potent compounds in all the screening methods. In vitro kinetic study of 35 showed mixed or non-competitive type of inhibition with 5-LOX enzyme. Presence of AOCH3 group in 35 and ACl in 33 at C6-position of benzothiazole ring were found very important substitutions for potent activityen_US
dc.publisherElsevieren_US
dc.relation.ispartofseriesIPFP0300;-
dc.subject7-Substituted coumarinsen_US
dc.subjectAnti-inflammatory and analgesic agentsen_US
dc.subject5-Lipoxygenase inhibitorsen_US
dc.subjectDockingen_US
dc.titleSynthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivativesen_US
dc.typeFaculty Papersen_US
Appears in Collections:Faculty Papers

Files in This Item:
File Description SizeFormat 
IPFP0300.pdfIPFP03001.36 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.